[{"id":"491ac971-1fca-48d9-9e1d-97a968bb7ba8","acronym":"RG9213011","url":"https://clinicaltrials.gov/study/NCT01865617","created_at":"2021-01-18T08:20:44.137Z","updated_at":"2024-07-02T16:36:09.928Z","phase":"Phase 1/2","brief_title":"Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia","source_id_and_acronym":"NCT01865617 - RG9213011","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JCAR014"],"overall_status":"Completed","enrollment":" Enrollment 204","initiation":"Initiation: 05/22/2013","start_date":" 05/22/2013","primary_txt":" Primary completion: 03/26/2021","primary_completion_date":" 03/26/2021","study_txt":" Completion: 03/26/2021","study_completion_date":" 03/26/2021","last_update_posted":"2022-05-25"}]